Ankylosing spondylitis

MD IQ

Conference Coverage

FDA’s Woodcock: Give biosimilars a chance

BOSTON – Biosimilar drugs are not identical twins of original biologic agents, but there are very strong family ties, and the newcomer is expected...

Pages